ONC.TO - Oncolytics Biotech Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/201412/31/2013
Total Revenue----
Cost of Revenue----
Gross Profit----
Operating Expenses
Research Development8,439.1798,601.86413,824.25218,506.064
Selling General and Administrative5,524.55,315.8374,998.6945,392.66
Non Recurring----
Others----
Total Operating Expenses13,963.67913,917.70118,822.94623,898.724
Operating Income or Loss-13,963.679-13,917.701-18,822.946-23,898.724
Income from Continuing Operations
Total Other Income/Expenses Net-1,166.926197.859210.39371.485
Earnings Before Interest and Taxes-13,963.679-13,917.701-18,822.946-23,898.724
Interest Expense----
Income Before Tax-15,130.605-13,719.842-18,612.556-23,527.239
Income Tax Expense9.3743.1536.7795.408
Minority Interest----
Net Income From Continuing Ops-15,139.979-13,722.995-18,619.335-23,532.647
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-15,139.979-13,722.995-18,619.335-23,532.647
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-15,139.979-13,722.995-18,619.335-23,532.647